Objective: Isolated spontaneous dissection of the superior mesenteric artery (SMA) and celiac artery (CA) remains a rare condition; however, it has been increasingly noted incidentally on diagnostic imaging. The purpose of this study was to examine the natural history and outcomes of patients presenting with isolated spontaneous mesenteric artery dissection (SMAD). We hypothesized that most SMADs can be treated nonoperatively.
Isolated spontaneous dissection of the superior mesenteric artery (SMA) and celiac artery (CA) remains a rare condition. However, it has been increasingly noted incidentally on diagnostic imaging. Roughly 200 cases of CA dissection have been reported in the literature, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] and fewer than 250 cases of SMA dissection have been reported 7, [10] [11] [12] 14, 17, 19, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] ; thus, the optimal management strategy remains poorly defined. Because of the increased use of cross-sectional imaging, a large number of spontaneous mesenteric artery dissections (SMADs) are found incidentally. Patients may also present with symptoms, predominantly composed of back pain, abdominal pain, and flank pain. The current evidence is derived from small series or case reports. A growing number of SMADs are treated conservatively by observation, antiplatelet therapy, or anticoagulation, with surgery or endovascular therapy reserved for bowel ischemia or aneurysmal degeneration.
Factors likely influencing the nature of SMAD include a history of connective tissue disorder, such as fibromuscular dysplasia (FMD), and segmental arterial mediolysis (SAM). In addition, whether patients presented with symptoms or the dissection was found incidentally may influence treatment algorithms. Because these and other observations are not well defined in the literature, we sought to investigate our population of patients.
The purpose of this study was to examine the natural history and outcomes of our patients presenting with isolated SMADs. We hypothesized that most SMADs in our population of patients would be treated nonoperatively.
METHODS
Study population. A retrospective study of patients presenting with SMAD at Northwestern Memorial Hospital between 2006 and 2016 was conducted using a systematic query of our medical records system. Patients having the diagnosis code for arterial dissection were selected. Inclusion criteria required dissection of the CA or SMA. Patients with aortic dissection or a history of recent trauma were excluded. The study was approved by the Northwestern Institutional Review Board with the requirement to obtain informed consent waived.
Characteristics of the patients including demographics, medical risk factors for dissection, and presentation (asymptomatic vs symptomatic) were recorded. Patients were considered symptomatic if they presented with abdominal pain, back pain, or flank pain. The remainder of the patients who were considered asymptomatic were diagnosed on imaging for followup of an alternative disease process or cardiopulmonary evaluation. The majority of patients were diagnosed by use of computed tomography angiography (CTA), which was reviewed for location, extent, and characterization of dissection. Treatment course as determined by the primary clinical team, including observation, antiplatelet therapy (which included aspirin or clopidogrel), systemic anticoagulation therapy (including unfractionated heparin, enoxaparin, warfarin, or any of the novel oral anticoagulants), and surgical or endovascular management, was recorded. Subsequent follow-up visits were noted to determine the length of therapy, resolution or progression of dissection, or aneurysmal degeneration.
Anatomic description. All CTA studies were interpreted by a radiologist from the cardiovascular imaging faculty, and individual images were reviewed by a senior vascular fellow for evaluation of the involved artery including maximum diameter, length of dissection, distance of dissection from the ostium of the vessel, and anatomic classification previously described for SMA dissection 23 or CA dissection. 5 Statistics. Data were collected and stored using Microsoft Excel (Microsoft Corp, Redmond, Wash) and analyzed using Stata (version 14; StataCorp LP, College Station, Tex). Continuous variables were compared using an independent t-test. The c 2 and Fisher exact tests were used for binary variables between symptomatic and asymptomatic patients. Simple logistic regression was used to analyze factors associated with intervention, defined as invasive diagnostic intervention, endovascular therapy, or surgery.
RESULTS
There were 77 patients found to have SMAD during the observation period. The mean age was 56 years (range, 26-86 years), and the majority (80.5%) were male. Demographics of the patients are displayed in Table I . When stratified by affected artery, 33 (43%) patients had CA dissection only, 30 (39%) had SMA dissection only, and 14 (18%) had concomitant CA and SMA dissection (Fig 1) .
All arteries were measured and classified according to anatomic descriptors. There were 42 CAs and 43 SMAs with radiographic imaging appropriate for evaluation of anatomic classification. Whereas a majority of patients (64.9%) presented with symptoms, including abdominal pain, back pain, and flank pain, there were 27 patients (35%) who were asymptomatic. All asymptomatic patients were managed nonoperatively; 33% were treated with observation, 41% with antiplatelet therapy, and 22% with anticoagulation (Table III) . Duration of antiplatelet therapy tended to be indefinite unless there was a contraindication, and duration of anticoagulation was an average of 3 months. Follow-up imaging was available at a median of 36 months (range, 1-84 months) for 26 arteries; 15 remained stable over time (8 CAs, 7 SMAs), whereas 10 resolved (5 CAs, 5 SMAs), and 1 SMA demonstrated mild aneurysmal degeneration that did not require intervention.
Whereas all patients with incidental mesenteric dissection were treated nonoperatively, the majority of the 50 patients presenting with symptoms were still managed nonoperatively; 2% were treated with observation, 24% Recommendation: This study suggests that most patients with spontaneous mesenteric artery dissection can be managed nonoperatively.
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were treated with antiplatelet therapy alone, and 68% were treated with anticoagulation. Duration of antiplatelet therapy tended to be indefinite unless there was a contraindication, and duration of anticoagulation was an average of 5 months. Despite presenting with abdominal pain, only 8% of symptomatic patients required operative intervention. On follow-up imaging at a median of 6 months (range, <1-108 months), there were 36 arteries not requiring intervention available for review. Twenty-nine remained stable (14 CAs, 15 SMAs), 4 resolved (all SMAs), and 3 demonstrated mild aneurysmal dilation (2 CAs, 1 SMAs). For all patients in the study, both asymptomatic and symptomatic on presentation, the mortality during the follow-up period was 9.1%, with no deaths attributed to mesenteric artery dissection or mesenteric ischemia.
Comparisons were made between patients who presented with symptoms and those who were asymptomatic. Patients who were asymptomatic were younger (53.9 6 11.4 years vs 58.7 6 11.2 years; P ¼ .032). There were no significant differences in artery involved (CA vs SMA) between patients with and patients without symptoms; however, there was a trend toward SMA involvement in symptomatic patients (23 [46%] vs 7 [26%]; P ¼ .085). Patients who were symptomatic were more likely to receive a vascular surgery consultation (96% vs 74%; P ¼ .004). Patients who were asymptomatic were more likely to be treated only with observation (33% vs 2%; P < .001), whereas patients who were symptomatic were more likely to be treated with anticoagulation or antiplatelet therapy (68% vs 22%; P < .001). Although all four patients who required intervention were symptomatic, there was not a statistically significant difference between symptomatic and asymptomatic patients requiring surgical or endovascular intervention. However, because of the low number of interventions, the study was underpowered to detect this difference.
All four patients requiring intervention presented initially with symptoms. Three patients required surgical intervention, and one patient required endovascular intervention (Table IV) . The first patient was transferred in with abdominal pain and CA and SMA dissection on CTA. He was started on anticoagulation with heparin but developed worsening pain on presentation. He underwent immediate exploratory laparotomy demonstrating a thrombosed SMA. He was revascularized with an SMA and ileocolic endarterectomy with patch angioplasty using bovine pericardium. He did not require bowel resection. The second patient presented with abdominal pain and was found to have an SMA dissection on CTA. She was initially treated with anticoagulation with heparin, but her pain worsened. She underwent exploratory laparotomy demonstrating viable but dusky bowel and an SMA dissection. She underwent bypass from the left common iliac artery to a branch of the SMA using greater saphenous vein as a conduit. The third patient presented with an SMA dissection with minimal pain. He was initially treated with anticoagulation and inpatient observation but progressed to SMA occlusion on subsequent CTA and developed worsening abdominal pain. On hospital day 9, he developed peritonitis and underwent aortomesenteric bypass using polytetrafluoroethylene as a conduit to a branch of the SMA. The final patient presented with concomitant SMA and CA dissection. He presented with right upper quadrant pain, which remained stable. He was initially treated with anticoagulation therapy; however, on 4-week follow-up CTA, he had aneurysmal degeneration of the dissected CA and hepatic artery measuring 2.1 cm. This was treated by a covered stent graft. All three patients treated with mesenteric revascularization for SMA occlusion did not require bowel resection and had complete restoration of true luminal flow on follow-up imaging (Fig 2) . Simple logistic regression was performed to evaluate factors associated with any intervention, including surgical, endovascular, and invasive diagnostic testing.
Although the majority of demographics, symptom status, and treatment did not predict any intervention, patients presenting with SMAD and angiographic findings suggestive of FMD or SAM were more likely to undergo intervention (odds ratio, 8.1; 95% confidence interval, 1.002-65.889; P ¼ .05).
DISCUSSION
In our population of 77 patients, we found the majority to be male and to have hypertension. There were similar numbers of patients presenting with CA dissection and SMA dissection and a small population presenting with both. Asymptomatic patients, which represented 35% of the cohort, were all managed nonoperatively, with the majority managed with observation (33%) or antiplatelet therapy (41%) and 22% with anticoagulation. This resulted in most resolving or stabilizing on follow-up imaging and none requiring intervention. Symptomatic patients were more likely to be treated with anticoagulation (68%) rather than with observation (2%) or antiplatelet therapy alone (24%) compared with asymptomatic patients. Despite presenting with symptoms, only 8% of these patients required operative management (1 SMA endarterectomy and patch angioplasty, 2 aortomesenteric bypasses to a branch of the SMA, and 1 hepatic artery stent graft). These results demonstrated an institutional bias toward nonoperative management in all patients with mesenteric dissection in the absence of worsening symptoms. This was successful in all asymptomatic patients, and of the four symptomatic patients who did progress to require intervention, none required bowel resection. Although the mechanism of SMAD is largely unknown, 13% of our population presenting with SMAD had angiographic findings suggestive of SAM or FMD. Slavin and Gonzalez-Vitale in 1976 37 were the first to describe SAM; this condition has a predilection for visceral arteries. It is a nonatherosclerotic, noninflammatory disease with unknown etiology. The characteristic lesion is mediolysis in the outer media, which may extend inward to involve almost all the inner media. The mediolysis is produced by expanding vacuoles within the cytoplasm of the smooth muscle cells. 38, 39 The vacuoles enlarge to a point at which the cell ruptures and the media is lost. A process of healing occurs whereby granulation tissue fills the media, which may lead to hemorrhage from ruptures, dissecting hematomas, and aneurysmal enlargement. In addition, there may be separation of the outer media from the adventitia that fills the vessel with granulation tissue, forming a fibrous organization that is not dissimilar to medial FMD. The arterial lesions are segmental and may involve part of the entire arterial wall circumference. The early phases of the process are asymptomatic and become evident only when a complication occurs. Several reports have detailed involvement of multiple arteries. We did not send samples for pathologic examination or perform genetic testing in any of our patients; thus, it is difficult to determine the true incidence of SAM and FMD, but this is an important factor to consider going forward in the management of SMAD. 
Fig 2.
Computed tomography angiography (CTA) of a patient presenting with spontaneous mesenteric artery dissection (SMAD; A). He was treated with anticoagulation, but during a period of 9 days, he progressed to complete superior mesenteric artery (SMA) occlusion with symptoms of bowel ischemia (B). He was treated with mesenteric bypass to a branch of the SMA with restoration of flow to the true lumen (C). The arrows point to the affected segment of the SMA. Mesenteric artery dissection is described in the literature mostly in the form of case studies or small case series. Although there are no randomized trials of optimal treatment for SMAD, it is worth looking to the literature on cervical carotid dissections. The Cervical Artery Dissection in Stroke Study (CADISS) randomized 250 patients to antiplatelet vs anticoagulation therapy and found no differences in preventing stroke or death in this population of patients. 40 We reviewed >30 published studies on SMAD to compare different management strategies. The results of this review are summarized in Table V . Several studies recommended treatment with observation alone rather than with anticoagulation. 4, 7, 12, 22, 23, 28, 31 In our series, only 13% of all patients were treated with observation alone. This may reflect our high number of symptomatic patients, who were more often treated with anticoagulation. There does not seem to be a difference in studies on CA and SMA dissection with regard to treatment with observation compared with anticoagulation. For example, in the study of DiMusto et al, 4 which focused on 19 patients with isolated CA dissection, only 37% were symptomatic; however, three of them went on to receive stenting for persistent abdominal pain. with CA (6) and SMA (17) dissections; only 4 were treated with observation alone, 13 were treated with antiplatelet therapy or anticoagulation, and 6 received endovascular stents. Many of these studies suggest a much lower rate of anticoagulation but a much higher rate of stenting (15%-65%) compared with our series, in which only one patient received a stent graft for aneurysmal dilation. In this study, we found an institutional bias toward nonoperative management for all patients with SMAD. Our treatment of asymptomatic patients tended toward observation and antiplatelet therapy with a small cohort treated with anticoagulation, whereas our treatment of symptomatic patients tended toward anticoagulation over antiplatelet therapy or observation alone. In addition, symptomatic patients tended to be treated with a longer course of anticoagulation, with an average of 5 months compared with 3 months in asymptomatic patients. Weaknesses of this study include its retrospective nature and that data are from a single institution. Whereas treatment was up to the clinical judgment of each treating physician, even within our group, there was wide disparity between the use of observation, antiplatelet therapy, and anticoagulation. It is clear, though, that only a small percentage of patients require operative management. Patients presenting with signs of bowel ischemia require operative management, but further study on the need for antiplatelet therapy vs anticoagulation and the need for subsequent surveillance imaging to evaluate for aneurysmal dilation would be helpful to better guide practice patterns. In addition, as none of our patients presented initially with symptomatic acute mesenteric ischemia, it is possible that we are missing a cohort of patients who may have presented initially with signs of acute mesenteric ischemia and required immediate bowel exploration before any form of imaging, thus making the diagnosis of mesenteric dissection impossible. Nevertheless, the benign course that we observed in the patients diagnosed with dissection and who were closely followed up suggests that severe symptomatic ischemia leading to bowel infarction is not a common occurrence. Our follow-up imaging is limited in scope, with 26% of patients lost to follow-up and a wide range of duration of follow-up. There were only 57 patients with studies available for follow-up, including 46 computed tomography scans, 20 mesenteric duplex ultrasound examinations, and 3 magnetic resonance imaging scans, with some patients having more than one modality. We hope to continue to accumulate data regarding long-term follow-up of these patients.
CONCLUSIONS
In this retrospective review of 77 patients, we found that spontaneous dissections occurred in nearly equal number in the CA and SMA, and most were symptomatic. We managed most dissections without invasive intervention. Most asymptomatic patients received antiplatelet therapy alone. Anticoagulation was used mainly in symptomatic patients and those with luminal compromise. Patients with bowel ischemia were treated by operative exploration and revascularization with either SMA endarterectomy and patch angioplasty to patent branches or bypass to a branch of the SMA despite occlusion of the main branch. In the two cases in which we used a nondissected branch of the SMA as a target, complete lumen restoration of the occluded SMA has been observed over time.
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